Physician profile
Michael Weber
NPI 1073827317
$4,203.24
in general payments reported to CMS, 2019-2025
9 companies · $3,558 in 2025
The $3,558 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $646 · 2025: $3,558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,908 · Consulting Fee: $1,650 · Travel and Lodging: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,907.70 |
| Consulting Fee | $1,650.00 |
| Travel and Lodging | $645.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $1,852.35 | 2025 | Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm, Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm |
| Depuy Synthes Sales INC. | $744.62 | 2025 | Velys, Trialtis |
| Stryker Corporation | $645.54 | 2024 | N/A |
| Vb Spine LLC | $313.98 | 2025 | Lite Bio Delivery System, Na |
| Spine Wave, INC. | $219.12 | 2025 | Proficient Posterior Cervical Spine System, Salvo Spine System |
| Augmedics INC. | $202.81 | 2025 | Xvision |
| Intrinsic Therapeutics | $160.67 | 2025 | Barricaid Acd (Annular Closure Device) |
| Kuros Biosciences USA, INC | $42.30 | 2025 | Magnetos |
| Convatec INC. | $21.85 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.